Bedside endoscopic ultrasound in critically ill patients

John DeWitt, Mehdi Mohamadnejad, Julia K. Leblanc, Stuart Sherman, Mohammad Al-Haddad, Lee McHenry, Gregory A. Cote

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background. The aim of this study was to evaluate the role and impact of EUS in the management of critically ill patients. Methods. We retrospectively identified all patients at our institution over a 68-month period in whom bedside inpatient EUS was performed. EUS was considered to have a significant impact if a new diagnosis was established and/or the findings altered subsequent clinical management. Results. Fifteen patients (9 male; mean age 58 ± 15 years) underwent bedside EUS without complications. EUS-FNA (median 4 passes; range 2-7) performed in 12 (80%) demonstrated a malignant mediastinal mass/lymph node (5), pancreatic abscess (1), excluded a pelvic abscess (1), established enlarged gastric folds as benign (1) and excluded malignancy in enlarged mediastinal (1) and porta hepatis adenopathy (1). In two patients, EUS-FNA failed to diagnose mediastinal histoplasmosis (1) and a hemorrhagic pancreatic pseudocyst (1). In three diagnostic exams without FNA, EUS correctly excluded choledocholithaisis (n = 1) and cholangiocarcinoma (1), and found gastric varices successfully thrombosed after previous cyanoacrylate injection (1). EUS was considered to have an impact in 13/15 (87%) patients. Conclusions. In this series, bedside EUS in critically ill patients was technically feasible, safe and had a major impact on the majority of patients.

Original languageEnglish
Article number529791
JournalDiagnostic and Therapeutic Endoscopy
DOIs
StatePublished - 2011

Fingerprint

Critical Illness
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Abscess
Cyanoacrylates
Pancreatic Pseudocyst
Histoplasmosis
Cholangiocarcinoma
Esophageal and Gastric Varices
Inpatients
Stomach
Thrombosis
Lymph Nodes
Injections
Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Bedside endoscopic ultrasound in critically ill patients. / DeWitt, John; Mohamadnejad, Mehdi; Leblanc, Julia K.; Sherman, Stuart; Al-Haddad, Mohammad; McHenry, Lee; Cote, Gregory A.

In: Diagnostic and Therapeutic Endoscopy, 2011.

Research output: Contribution to journalArticle

DeWitt, John ; Mohamadnejad, Mehdi ; Leblanc, Julia K. ; Sherman, Stuart ; Al-Haddad, Mohammad ; McHenry, Lee ; Cote, Gregory A. / Bedside endoscopic ultrasound in critically ill patients. In: Diagnostic and Therapeutic Endoscopy. 2011.
@article{5bd22efa27df475d880de24e9e93dd62,
title = "Bedside endoscopic ultrasound in critically ill patients",
abstract = "Background. The aim of this study was to evaluate the role and impact of EUS in the management of critically ill patients. Methods. We retrospectively identified all patients at our institution over a 68-month period in whom bedside inpatient EUS was performed. EUS was considered to have a significant impact if a new diagnosis was established and/or the findings altered subsequent clinical management. Results. Fifteen patients (9 male; mean age 58 ± 15 years) underwent bedside EUS without complications. EUS-FNA (median 4 passes; range 2-7) performed in 12 (80{\%}) demonstrated a malignant mediastinal mass/lymph node (5), pancreatic abscess (1), excluded a pelvic abscess (1), established enlarged gastric folds as benign (1) and excluded malignancy in enlarged mediastinal (1) and porta hepatis adenopathy (1). In two patients, EUS-FNA failed to diagnose mediastinal histoplasmosis (1) and a hemorrhagic pancreatic pseudocyst (1). In three diagnostic exams without FNA, EUS correctly excluded choledocholithaisis (n = 1) and cholangiocarcinoma (1), and found gastric varices successfully thrombosed after previous cyanoacrylate injection (1). EUS was considered to have an impact in 13/15 (87{\%}) patients. Conclusions. In this series, bedside EUS in critically ill patients was technically feasible, safe and had a major impact on the majority of patients.",
author = "John DeWitt and Mehdi Mohamadnejad and Leblanc, {Julia K.} and Stuart Sherman and Mohammad Al-Haddad and Lee McHenry and Cote, {Gregory A.}",
year = "2011",
doi = "10.1155/2011/529791",
language = "English",
journal = "Diagnostic and Therapeutic Endoscopy",
issn = "1070-3608",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Bedside endoscopic ultrasound in critically ill patients

AU - DeWitt, John

AU - Mohamadnejad, Mehdi

AU - Leblanc, Julia K.

AU - Sherman, Stuart

AU - Al-Haddad, Mohammad

AU - McHenry, Lee

AU - Cote, Gregory A.

PY - 2011

Y1 - 2011

N2 - Background. The aim of this study was to evaluate the role and impact of EUS in the management of critically ill patients. Methods. We retrospectively identified all patients at our institution over a 68-month period in whom bedside inpatient EUS was performed. EUS was considered to have a significant impact if a new diagnosis was established and/or the findings altered subsequent clinical management. Results. Fifteen patients (9 male; mean age 58 ± 15 years) underwent bedside EUS without complications. EUS-FNA (median 4 passes; range 2-7) performed in 12 (80%) demonstrated a malignant mediastinal mass/lymph node (5), pancreatic abscess (1), excluded a pelvic abscess (1), established enlarged gastric folds as benign (1) and excluded malignancy in enlarged mediastinal (1) and porta hepatis adenopathy (1). In two patients, EUS-FNA failed to diagnose mediastinal histoplasmosis (1) and a hemorrhagic pancreatic pseudocyst (1). In three diagnostic exams without FNA, EUS correctly excluded choledocholithaisis (n = 1) and cholangiocarcinoma (1), and found gastric varices successfully thrombosed after previous cyanoacrylate injection (1). EUS was considered to have an impact in 13/15 (87%) patients. Conclusions. In this series, bedside EUS in critically ill patients was technically feasible, safe and had a major impact on the majority of patients.

AB - Background. The aim of this study was to evaluate the role and impact of EUS in the management of critically ill patients. Methods. We retrospectively identified all patients at our institution over a 68-month period in whom bedside inpatient EUS was performed. EUS was considered to have a significant impact if a new diagnosis was established and/or the findings altered subsequent clinical management. Results. Fifteen patients (9 male; mean age 58 ± 15 years) underwent bedside EUS without complications. EUS-FNA (median 4 passes; range 2-7) performed in 12 (80%) demonstrated a malignant mediastinal mass/lymph node (5), pancreatic abscess (1), excluded a pelvic abscess (1), established enlarged gastric folds as benign (1) and excluded malignancy in enlarged mediastinal (1) and porta hepatis adenopathy (1). In two patients, EUS-FNA failed to diagnose mediastinal histoplasmosis (1) and a hemorrhagic pancreatic pseudocyst (1). In three diagnostic exams without FNA, EUS correctly excluded choledocholithaisis (n = 1) and cholangiocarcinoma (1), and found gastric varices successfully thrombosed after previous cyanoacrylate injection (1). EUS was considered to have an impact in 13/15 (87%) patients. Conclusions. In this series, bedside EUS in critically ill patients was technically feasible, safe and had a major impact on the majority of patients.

UR - http://www.scopus.com/inward/record.url?scp=80052656358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052656358&partnerID=8YFLogxK

U2 - 10.1155/2011/529791

DO - 10.1155/2011/529791

M3 - Article

JO - Diagnostic and Therapeutic Endoscopy

JF - Diagnostic and Therapeutic Endoscopy

SN - 1070-3608

M1 - 529791

ER -